Healthcare >> CEO Interviews >> April 26, 1999
DANIEL G. HOLMAN is Chairman, President & CEO of Uroplasty, Inc. Prior
to joining the company Mr. Holman was Chairman & CEO at Bio-Vascular,
Inc. He was educated at the University of Minnesota-St. Cloud, receiving
a BA in Biology in 1968. Mr. Holman's honors and awards include
University of Minnesota - St. Cloud Vice President, National Academy of
Science, 1965; American Legion Certificate of Commendation, 1975;
Institute de Intellegencia, Athens, Greece, Award for Service to the
People of Greece, 1977 and State of Minnesota Governor's Award for
Business Achievement, 1989. His current associations and affiliations
include: American Association of Medical Manufacturers; American
Association for the Advancement of Science and New York Academy of
Science. Among the patents issued to Mr. Holman are: U.S. Patent
#4,240,794: performing vascular grafts; U. S. Patent #4,239,492:
preparing vascular grafts for implantation; U.S. Patent #4,422,759:
Photographic Accessory: U.S. Patent #4,456,589: Preparation of Animal
Tissues for Surgical Implantation in Human Recipients; U.S. Paten
#D262,265: Handpan; U.S. Patent #4,780,168: Wound closure strips; U.S.
Patent #4,915,113: Method for monitoring patency of vascular grafts;
U.S. Patent #4,950,282: Wound closure strips and U.S. Patent #4,950,699:
Wound dressing incorporating collagen in adhesive layer. Profile
customers, those kinds of things?
Mr. Holman: Uroplasty was incorporated in 1992 as a urological medical
device
